Abu Dhabi: PureHealth, the largest healthcare platform in the Middle East, has partnered with Dell Technologies, an American multinational technology company.
The partnership aims to utilize generative artificial intelligence (GenAI) across healthcare services including early disease detection, medical data analysis, and personalized treatment plans, further enhancing the health ecosystem in Abu Dhabi.
According to the statement, the collaboration will leverage the collective resources and technologies of both companies to improve health outcomes by ensuring access to leading medical solutions and services and accelerating long-term preparedness and agility.
PureHealth intends to improve patient experiences through intelligent healthcare decision-making and advance health research with the use of Dell’s innovative solutions, hence improving community wellness.
GenAI has many benefits for the healthcare industry, from early disease detection by analyzing extensive medical data, to personalized treatment plans based on individual patient profiles. Additionally, GenAl can enhance medical imaging accuracy, help with predictive analytics for disease outbreaks, and speed up drug discovery, all of which contribute to a more effective and patient-centered healthcare system.
The collaboration was signed by Mr. Junaid Khan, Chief Technology Officer at PureHealth, and Mr. Walid Yehia, the UAE’s General Manager of Dell Technologies. Mr. Michael Dell, Founder, Chairman, and CEO of Dell Technologies, and Mr. Farhan Malik, Founder, Managing Director, and CEO of PureHealth, witnessed the signing of the collaboration between both organizations.
As we embark on this transformative journey with Dell, we are thrilled to pioneer a new era in healthcare. This collaboration signifies our unwavering commitment to advancing the future of healthcare by harnessing the rapidly increasing computing power and normalizing GenAI-based outcomes. By integrating GenAI, we are poised to revolutionize the industry, improve health outcomes, and fortify our healthcare system’s readiness for the future. Our efforts align seamlessly with our vision of extending the human health span. GenAI is a powerful tool and will be incorporated in our digital transformation where we aim to take healthcare to the cloud.
Mr. Junaid Khan, Chief Technology Officer at PureHealth, shared.
Mr. Yehia remarked that, “GenAI continues to drive meaningful conversations and propel tangible progress across industries. We are using our position as the world’s broadest GenAI infrastructure portfolio provider to help PureHealth deliver critical services to citizens.”
The partnership strengthens PureHealth’s position as a leading global healthcare provider in the wake of the milestone acquisitions of Ardent Health Services, the US’s fourth-largest private healthcare group, and Circle Health Group, the UK’s largest private healthcare group. This growth path underscores Abu Dhabi’s vision to bolster its position as a leading global destination for healthcare and life sciences.